» Articles » PMID: 32477246

Impaired Phasic Discharge of Locus Coeruleus Neurons Based on Persistent High Tonic Discharge-A New Hypothesis With Potential Implications for Neurodegenerative Diseases

Overview
Journal Front Neurol
Specialty Neurology
Date 2020 Jun 2
PMID 32477246
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The locus coeruleus (LC) is a small brainstem nucleus with widely distributed noradrenergic projections to the whole brain, and loss of LC neurons is a prominent feature of age-related neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD). This article discusses the hypothesis that in early stages of neurodegenerative diseases, the discharge mode of LC neurons could be changed to a persistent high tonic discharge, which in turn might impair phasic discharge. Since phasic discharge of LC neurons is required for the release of high amounts of norepinephrine (NE) in the brain to promote anti-inflammatory and neuroprotective effects, persistent high tonic discharge of LC neurons could be a key factor in the progression of neurodegenerative diseases. Transcutaneous vagal stimulation (t-VNS), a non-invasive technique that potentially increases phasic discharge of LC neurons, could therefore provide a non-pharmacological treatment approach in specific disease stages. This article focuses on LC vulnerability in neurodegenerative diseases, discusses the hypothesis that a persistent high tonic discharge of LC neurons might affect neurodegenerative processes, and finally reflects on t-VNS as a potentially useful clinical tool in specific stages of AD and PD.

Citing Articles

Autonomic Disequilibrium at Rest in Autistic Children and Adults.

Bufo M, Guidotti M, Lemaire M, Malvy J, Houy-Durand E, Bonnet-Brilhault F Appl Psychophysiol Biofeedback. 2025; .

PMID: 39982620 DOI: 10.1007/s10484-025-09696-z.


Aperiodic spectral slope tracks the effects of brain state on saliency responses in the human auditory cortex.

Mocchi M, Bartoli E, Magnotti J, de Gee J, Metzger B, Pascuzzi B Sci Rep. 2024; 14(1):30751.

PMID: 39730513 PMC: 11681213. DOI: 10.1038/s41598-024-80911-3.


Neuroprotective actions of norepinephrine in neurological diseases.

Ghasemi M, Mehranfard N Pflugers Arch. 2024; 476(11):1703-1725.

PMID: 39136758 DOI: 10.1007/s00424-024-02999-w.


Insulin restores retinal ganglion cell functional connectivity and promotes visual recovery in glaucoma.

El Hajji S, Shiga Y, Belforte N, Solorio Y, Tastet O, DOnofrio P Sci Adv. 2024; 10(32):eadl5722.

PMID: 39110798 PMC: 11305393. DOI: 10.1126/sciadv.adl5722.


Greater physical fitness ( ) in healthy older adults associated with increased integrity of the locus coeruleus-noradrenergic system.

Plini E, Melnychuk M, Andrews R, Boyle R, Whelan R, Spence J Acta Physiol (Oxf). 2024; 240(8):e14191.

PMID: 38895950 PMC: 11250687. DOI: 10.1111/apha.14191.


References
1.
McMillan P, White S, Franklin A, Greenup J, Leverenz J, Raskind M . Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease. Brain Res. 2010; 1373:240-52. PMC: 3038670. DOI: 10.1016/j.brainres.2010.12.015. View

2.
Eser R, Ehrenberg A, Petersen C, Dunlop S, Mejia M, Suemoto C . Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study. J Neuropathol Exp Neurol. 2018; 77(2):149-161. PMC: 6251636. DOI: 10.1093/jnen/nlx113. View

3.
Manta S, El Mansari M, Debonnel G, Blier P . Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems. Int J Neuropsychopharmacol. 2012; 16(2):459-70. DOI: 10.1017/S1461145712000387. View

4.
Matschke L, Rinne S, Snutch T, Oertel W, Dolga A, Decher N . Calcium-activated SK potassium channels are key modulators of the pacemaker frequency in locus coeruleus neurons. Mol Cell Neurosci. 2018; 88:330-341. DOI: 10.1016/j.mcn.2018.03.002. View

5.
Rommelfanger K, Weinshenker D . Norepinephrine: The redheaded stepchild of Parkinson's disease. Biochem Pharmacol. 2007; 74(2):177-90. DOI: 10.1016/j.bcp.2007.01.036. View